1. Home
  2. CADL vs GUT Comparison

CADL vs GUT Comparison

Compare CADL & GUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$9.46

Market Cap

694.6M

Sector

Health Care

ML Signal

HOLD

Logo Gabelli Utility Trust (The)

GUT

Gabelli Utility Trust (The)

HOLD

Current Price

$6.41

Market Cap

613.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
GUT
Founded
1999
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
694.6M
613.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CADL
GUT
Price
$9.46
$6.41
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
1.4M
291.7K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
10.93%
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$5.42
52 Week High
$11.36
$7.07

Technical Indicators

Market Signals
Indicator
CADL
GUT
Relative Strength Index (RSI) 50.20 44.34
Support Level $9.19 $6.12
Resistance Level $11.36 $6.70
Average True Range (ATR) 0.58 0.17
MACD -0.07 -0.07
Stochastic Oscillator 24.29 14.86

Price Performance

Historical Comparison
CADL
GUT

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About GUT Gabelli Utility Trust (The)

Gabelli Utility Trust operates as a diversified closed-end investment management company. The fund's primary objective is the long-term growth of capital and income. To achieve its objective, the fund may invest its assets in common stocks and other securities of foreign and domestic companies involved in providing products, services, or equipment for the generation or distribution of electricity, gas, & water; and telecommunications services or infrastructure operations. It invests in various sectors, of which Electric Integrated, Water, Telecommunications, and U.S. Government Obligations and others.

Share on Social Networks: